Skip to main content
SpringerLink
Log in

Chronisch entzündliche Darmerkrankungen

  • Chapter
Therapie gastroenterologischer Krankheiten

  • 1299 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Actis GC, Bresso F, Astegiano M et al. (2001) Safety and efficacy of azathioprine in the maintenance of cyclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther 15: 1307–1311

    Article  PubMed  Google Scholar 

  • Akobeng A, Zachos M (2004) Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst Rev 1: CD003574

    Google Scholar 

  • Akobeng AK, Miller V, Stanton J et al. (2000) Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 30: 78–84

    Article  PubMed  Google Scholar 

  • Anstee QM, Forbes A (2000) The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease. Eur J Gastroenterol Hepatol 12: 1089–1093

    PubMed  Google Scholar 

  • Ballegaard M, Bjergstrom A, Brondum S et al. (1997) Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 32: 569–571

    PubMed  Google Scholar 

  • Bauer JJ, Harris MT, Grumbach NM, Gorfine SR (1995) Laparoscopic-assisted intestinal resection for Crohn's disease. Dis Colon Rectum 38: 712–715

    Article  PubMed  Google Scholar 

  • Baumgart DC, Wiedenmann B, Dignass AU (2003) Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 17: 1273–1281

    Article  PubMed  Google Scholar 

  • Belluzzi A, Brignola C, Campieri M et al. (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334: 1557–1560

    Article  PubMed  Google Scholar 

  • Ben-Ami H, Ginesin Y, Behar DM et al. (2002) Diagnosis and treatment of urinary tract complications in Crohn's disease: an experience over 15 years. Can J Gastroenterol 16: 225–229

    PubMed  Google Scholar 

  • Bengmark S (2000) Colonic food: Pre-and probiotocs. Am J Gastroenterol 95: S5–S7

    Article  PubMed  Google Scholar 

  • Bertschinger P, Himmelmann A, Risti B, Follath F (1995) Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol 90: 330

    Google Scholar 

  • Bohm B, Milsom JW, Fazio VW (1994) Laparoscopic ileocecal resection in Crohn disease. Zentralbl Chir 119: 420–426

    PubMed  Google Scholar 

  • Bonaz B, Boitard J, Marteau P et al. (2003) Thioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment Pharmacol Ther 18: 401–408

    PubMed  Google Scholar 

  • Borley NR, Mortensen NJ, Jewell DP (1997) Preventing postoperative recurrence of Crohn's disease. Br J Surg 84: 1493–1502

    PubMed  Google Scholar 

  • Bregenzer N, Caesar I, Andus T et al. (1999) Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group. Z Gastroenterol 37: 999–1004

    PubMed  Google Scholar 

  • Buhr HJ, Heuschen UA, Stern J, Herfarth C (1993) Continence preserving operation after proctocolectomy. Indications, technique and results. Chirurg 64: 601–613

    PubMed  Google Scholar 

  • Buhr HJ, Heuschen UA, Stern J, Herfarth C (1994) Technique and results of the ileoanal pouch after proctocolectomy. Zentralbl Chir 119: 867–877

    PubMed  Google Scholar 

  • Camma C, Giunta M, Rosselli M, Cottone M (1997) Mesalamine in the maintenance treatment of Crohn's disease: a metaanalysis adjusted for confounding variables. Gastroenterology 113: 1465–1473

    Article  PubMed  Google Scholar 

  • Canin-Endres J, Salky B, Gattorno F, Edye M (1999) Laparoscopically assisted intestinal resection in 88 patients with Crohn's disease. Surg Endosc 13: 595–599

    Article  PubMed  Google Scholar 

  • Caro-Paton T, Carvajal A, Martin DI et al. (1997) Is metronidazole teratogenic? A metaanalysis. Br J Clin Pharmacol 44: 179–182

    Article  PubMed  Google Scholar 

  • Cashman KD, Shanahan F (2003) Is nutrition an aetiological factor for inflammatory bowel disease? Eur J Gastroenterol 15: 607–613

    Article  Google Scholar 

  • Choen S, Tsunoda A, Nicholls RJ (1991) Prospective randomized trial comparing anal function after hand sewn ileoanal anastomosis with mucosectomy versus stapled ileoanal anastomosis without mucosectomy in restorative proctocolectomy. Br J Surg 78: 430–434

    PubMed  Google Scholar 

  • Colombel JF, Ferrari N, Debuysere H et al. (2000) Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 118: 1025–1030

    PubMed  Google Scholar 

  • Connell W, Miller A (1999) Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 21: 311–323

    PubMed  Google Scholar 

  • Cox CL, Butts DR, Roberts MP, Wessels RA, Bailey HR (1997) Development of invasive adenocarcinoma in a longstanding Kock continent ileostomy: report of a case. Dis Colon Rectum 40: 500–503

    PubMed  Google Scholar 

  • Cuffari C, Hunt S, Bayless T (2001) Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 48: 642–646

    Article  PubMed  Google Scholar 

  • DäAlabaz O, Iroatulam AJ, Nessim A et al. (2000) Comparison of laparoscopically assisted and conventional ileocolic resection for Crohn's disease. Eur J Surg 166: 213–217

    Article  PubMed  Google Scholar 

  • De Vlam K, Mielants H, Cuvelier C et al. (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27: 2860–2865

    PubMed  Google Scholar 

  • Dehn TC, Kettlewell MG, Mortensen NJ et al. (1989) Ten-year experience of strictureplasty for obstructive Crohn's disease. Br J Surg 76: 339–341

    PubMed  Google Scholar 

  • Derijks LJ, de Jong DJ, Gilissen LP et al. (2003) 6-Thioguanine seems promising in azathioprine-or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Eur J Gastroenterol Hepatol 15: 63–67

    Article  PubMed  Google Scholar 

  • D'Haens G, Lemmens L, Geboes K et al. (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120: 1323–1329

    Article  PubMed  Google Scholar 

  • Diav-Citrin O, Park YH, Veerasuntharam G et al. (1998) The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114: 23–28

    PubMed  Google Scholar 

  • Domenech E, Garcia-Planella E, Bernal I et al. (2002) Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis. Aliment Pharmacol Ther 16: 2061–2065

    Article  PubMed  Google Scholar 

  • Dougados M, vam der Linden S, Leirisalo-Repo M et al. (1995) Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38: 618–627

    PubMed  Google Scholar 

  • Dozois RR, Nelson H, Metcalf AM (1993) Sexual function after ileo-anal anastomosis. Ann Chir 1993 47: 1009–1013

    PubMed  Google Scholar 

  • Ettinger B, Pak CY, Citron JT et al. (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158: 2069–2073

    PubMed  Google Scholar 

  • Evans JM, McMahon AD, Murray FE et al. (1997) Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40: 619–622

    PubMed  Google Scholar 

  • Evans RC, Clarke L, Heath P et al. (1997) Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571. Aliment Pharmacol Ther 11: 1031–1035

    Article  PubMed  Google Scholar 

  • Ewe K, Malchow H, Herfarth C (1984) Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study—initial results. Langen-becks Arch Chir 364: 427–430

    Article  Google Scholar 

  • Fazio VW, Marchetti F, Church M et al. (1996) Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 224: 563–571

    Article  PubMed  Google Scholar 

  • Fazio VW, Tjandra JJ, Lavery IC et al. (1993) Long-term follow-up of strictureplasty in Crohn's disease. Dis Colon Rectum 36: 355–361

    Article  PubMed  Google Scholar 

  • Feagan BG, Fedorak RN, Irvine EJ et al. (2000) A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 42: 1627–1632

    Article  Google Scholar 

  • Feagan BG, Rochon J, Fedorak RN et al. (1995) Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 332: 292–297

    Article  PubMed  Google Scholar 

  • Fedorak RN, Gangl A, Elson CO et al. (2000) Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 119: 1473–1482

    Article  PubMed  Google Scholar 

  • Fellermann K, Herrlinger KR, Witthoeft T et al. (2001) Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease. Transplant Proc 33: 2247–2248

    Article  PubMed  Google Scholar 

  • Fellermann K, Ludwig D, Stahl M et al. (1998) Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus Am J Gastroenterol 93: 1860–1866

    Article  PubMed  Google Scholar 

  • Fellermann K, Steffen M, Stein J et al. (2000) Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther 14: 171–176

    Article  PubMed  Google Scholar 

  • Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA (1995) How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A metaanalysis of the randomized clinical trials. J Parenter Enteral Nutr (JPEN) 19: 356–364

    Google Scholar 

  • Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL et al. (1999) Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Am J Gastroenterol 94: 427–433

    PubMed  Google Scholar 

  • Ferraz MB, Tugwell P, Goldsmith CH, Atra E (1990) Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol 17: 207–220

    Google Scholar 

  • Ford AC, Towler RJ, Moayyedi P et al. (2003) Mycophenolate mofetil in refractory inflammatory bowel disease. Aliment Pharmacol Ther 17: 1365–1369

    Article  PubMed  Google Scholar 

  • Fraser AG, Orchard TR, Jewell DP (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 50: 485–489

    Article  PubMed  Google Scholar 

  • Gasche C, Dejaco C, Waldhoer T et al. (1997) Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 126: 782–787

    PubMed  Google Scholar 

  • Gassull MA, Cabre E (2001) Nutrition in iflammatory bowel disease. Curr Opin Clin Nutr Metab Care 4: 561–569

    Article  PubMed  Google Scholar 

  • George J, Present DH, Pou R et al. (1996) The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 91: 1711–1714

    PubMed  Google Scholar 

  • Ghosh S, Goldin E, Malchow H et al. (2003) Natalizumab for active Crohn's disease. N Engl J Med 348: 24–32

    Article  PubMed  Google Scholar 

  • Gionchetti P, Rizzello F, Helwig U et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202–1209

    Article  PubMed  Google Scholar 

  • Gionchetti P, Rizzello F, Venturi A et al. (1999) Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 13: 713–718

    Article  PubMed  Google Scholar 

  • Gionchietti P, Rizzello F, Venturi A et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double blind, placebo-controlled trial. Gastroenterology 119: 305–309

    Article  PubMed  Google Scholar 

  • Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 108: 1056–1067

    Article  PubMed  Google Scholar 

  • Guslandi M, Mezzi G, Sorghi M, Testoni PA (2000) Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45: 1462–1464

    Article  PubMed  Google Scholar 

  • Hafraoui S, Dewit O, Marteau P et al. (2002) Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate. Gastroenterol Clin Biol 26: 17–22

    PubMed  Google Scholar 

  • Hanauer SB, Feagan BG, Lichtenstein GR et al. (2002) Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359: 1541–1549

    Article  PubMed  Google Scholar 

  • Hassard PV, Vasiliauskas EA, Kam LY et al. (2000) Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease. Inflamm Bowel Dis 6: 16–20

    PubMed  Google Scholar 

  • Hawthorne AB, Logan RF, Hawkey CJ et al. (1992) Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 30: 20–22

    Google Scholar 

  • Heppell J, Kelly K (1998) Pouchitis. Curr Opin Gastroenterology 14: 322–326

    Google Scholar 

  • Herfarth C, Bindewald H (1986) Perianal involvement in Crohn disease. Chirurg 57: 304–308

    PubMed  Google Scholar 

  • Herfarth H, Obermeier F, Andus T et al. (2002) Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease. Am J Gastroenterol 97: 2688–2690

    Article  PubMed  Google Scholar 

  • Herrlinger KR, Kreisel W, Schwab M et al. (2003) 6-thioguanine — efficacy and safety in chronic active Crohn's disease. Aliment Pharmacol Ther 17: 503–508

    Article  PubMed  Google Scholar 

  • Herrlinger KR, Witthöft T, Rädler A et al. (2004) Randomized, double-blind, double-dummy, controlled trial of subcutaneous recombinant human interleukin-11 vs. prednisolone in active Crohn's disease. Gastroenterology, Abstract DDW

    Google Scholar 

  • Heuschen UA, Autschbach F, Allemeyer EH et al. (2001) Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 44: 487–499

    PubMed  Google Scholar 

  • Heuschen UA, Heuschen G, Autschbach F et al. (2001) Adenocarcinoma in the ileal pouch: late risk of cancer after restorative proctocolectomy. Int J Colorectal Dis 16: 126–130

    Article  PubMed  Google Scholar 

  • Heuschen UA, Hinz U, Allemeyer EH et al. (2001) One-or two-stage procedure for restorative proctocolectomy: Rationale for a surgical strategy in ulcerative colitis. Ann Surg 234: 788–794

    Article  PubMed  Google Scholar 

  • Heuschkel RB, Menache CC, Megerian JT, Baird AE (2000) Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 31: 8–15

    Article  PubMed  Google Scholar 

  • Hildebrandt U, Ecker KW, Feifel G (1995) Minimally invasive surgery and Crohn disease. Chirurg 69: 915–921

    Article  Google Scholar 

  • Hildebrandt U, Schiedeck T, Kreissler-Haag D et al. (1998) Laparoscopically assisted surgery in Crohn disease. Zentralbl Chir 123: 357–361

    PubMed  Google Scholar 

  • Holtmeier J, Leuschner U (2001) Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Digestion 64: 137–150

    Article  PubMed  Google Scholar 

  • Hommes D, van den BB, Plasse T, Bartelsman J et al. (2002) Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 122: 7–14

    Article  PubMed  Google Scholar 

  • Hurst RD, Finco C, Rubin M, Michelassi F (1995) Prospective analysis of perioperative morbidity in one hundred consecutive colectomies for ulcerative colitis. Surgery 118: 748–754

    PubMed  Google Scholar 

  • Katz JA, Pore G (2001) Inflammatory bowel disease and pregnancy. Inflamm Bowel Dis 7: 146–157

    Article  PubMed  Google Scholar 

  • Keighley MR (1993) »Pouchitis«. Ann Chir 47: 1029–1033

    PubMed  Google Scholar 

  • Keranen U, Luukkonen P, Jarvinen H (1997) Functional results after restorative proctocolectomy complicated by pouchitis. Dis Colon Rectum 40: 764–769

    Article  PubMed  Google Scholar 

  • Klebl FH, Bregenzer N, Rogler G et al. (2003) Treatment of pouchitis with dehydroepiandrosterone (DHEA) Z Gastroenterol 4: 1087–1090

    Google Scholar 

  • Kmiot WA, Williams MR, Keighley MR (1990) Pouchitis following colectomy and ileal reservoir construction for familial adenomatous polyposis. Br J Surg 77: 1283

    PubMed  Google Scholar 

  • Kmiot WA, Youngs D, Tudor R et al. (1993) Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br J Surg 80: 1445–1449

    PubMed  Google Scholar 

  • Kotanagi H, Kramer K, Fazio VW, Petras RE (1991) Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? Retrospective analysis of 100 cases. Dis Colon Rectum 34: 909–916

    Article  PubMed  Google Scholar 

  • Kozarek RA, Patterson DJ, Gelfand MD et al. (1989) Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 110: 353–356

    PubMed  Google Scholar 

  • Kozlowski RD, Steinbrunner JV, MacKenzie AH et al. (1990) Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88: 589–592

    Article  PubMed  Google Scholar 

  • Kroesen AJ, Stern J, Buhr HJ, Herfarth C (1995) Incontinence after ileo-anal pouch anastomosis — diagnostic criteria and therapeutic sequelae. Chirurg 66: 385–391

    PubMed  Google Scholar 

  • Kruis W, Friè P, Stolte M, The Mutaflor Study Group (2001) Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine. Gastroenterology 120: A–127

    Google Scholar 

  • Kruis W, Schutz E, Fric P et al. (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11: 853–858

    Article  PubMed  Google Scholar 

  • Kuhbacher T, Schreiber S, Runkel N (1998) Pouchitis: pathophysiology and treatment. Int J Colorectal Dis 13: 196–207

    Article  PubMed  Google Scholar 

  • Lamah M, Scott HJ (2002) Inflammatory bowel disease and pregnancy. Int J Colorectal Dis 17: 216–222

    Article  PubMed  Google Scholar 

  • Lashner BA, Evans AA, Hanauer SB (1988) Preoperative total parenteral nutrition for bowel resection in Crohn's disease. Dig Dis Sci 34: 741–746

    Article  Google Scholar 

  • Lavery IC, Sirimarco MT, Ziv Y, Fazio VW (1995) Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. Dis Colon Rectum 38:03–806

    Article  Google Scholar 

  • Lee EC, Papaioannou N (1982) Minimal surgery for chronic obstruction in patients with extensive or universal Crohn's disease. Ann R Coll Surg Engl 64: 229–233

    PubMed  Google Scholar 

  • Lemann M, Zenjari T, Bouhnik YC et al. (2000) Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol 295: 1730–1734

    Google Scholar 

  • Lichtiger S, Present DH, Kornbluth A et al. (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841–1845

    Article  PubMed  Google Scholar 

  • Lindgren S, Lofberg R, Bergholm L et al. (2002) Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol 37: 705–710

    Article  PubMed  Google Scholar 

  • Lochs H, Mayer M, Fleig WE et al. (2000) Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 118: 264–273

    PubMed  Google Scholar 

  • Loebstein R, Addis E et al.(1998) Pregnancy outcome following gestational exposure to fluoroquinolones:a multicenter prospective controlled study. Antimicrob Agents Chemother 42: 1336–1339

    PubMed  Google Scholar 

  • Lorenz-Meyer H, Bauer P, Nicolay C et al. (1996) Omega-3-fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members. Scand J Gastroenterol 31: 778–785

    PubMed  Google Scholar 

  • Lowry PW, Franklin CL, Weaver AL et al. (2001) Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut 49: 665–670

    Article  PubMed  Google Scholar 

  • Luukkonen P, Jarvinen H, Tanskanen M, Kahri A (1994) Pouchitis—recurrence of the inflammatory bowel disease? Gut 35: 243–246

    PubMed  Google Scholar 

  • Makhdoom ZA, Komar MJ, Still CD (2000) Nutrition and enterocutaneous fistulas. J Clin Gastroenterol 31: 195–204

    Article  PubMed  Google Scholar 

  • Makowiec F, Jehle EC, Becker HD, Starlinger M (1995) Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn's disease. Br J Surg 82: 603–606

    PubMed  Google Scholar 

  • Marshall JK, Irvine EJ (1995) Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 20: 293–300

    Google Scholar 

  • Marteau P, Crand J, Foucault M, Rambaud JC (1998) Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study. Gut 42: 195–199

    PubMed  Google Scholar 

  • Mate-Jimenez J, Hermida C, Cantero-Perona J, Moreno-Otero R (2000) 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol 12: 1227–1233

    PubMed  Google Scholar 

  • Meijerink WJ, Eijsbouts QA, Cuesta MA et al. (1999) Laparoscopically assisted bowel surgery for inflammatory bowel disease. The combined experiences of two academic centers. Surg Endosc 13: 882–886

    Article  PubMed  Google Scholar 

  • Mekjihan HS, Switz DM, Watts HD et al. (1979) National cooperative Crohns disease study: Factors determnining recurrence of Crohn's diesease after surgery. Gastroenterology 77: 907–913

    PubMed  Google Scholar 

  • Metcalf AM, Dozois RR, Kelly KA (1986) Sexual function in women after proctocolectomy. Ann Surg 204: 624–627

    PubMed  Google Scholar 

  • Michelassi F, Melis M, Rubin M, Hurst RD (2000) Surgical treatment of anorectal complications in Crohn's disease. Surgery 128: 597–603

    Article  PubMed  Google Scholar 

  • Middleton SJ, Naylor S, Woolner J, Hunter JO (2002) A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther 16: 1131–1135

    Article  PubMed  Google Scholar 

  • Mikkola K, Luukkonen P, Jarvinen HJ (1995) Long-term results of restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis 10: 10–14

    Article  PubMed  Google Scholar 

  • Milsom JW, Casillas S (1996) Current status in laparoscopic colorectal surgery. Rev Gastroenterol Mex 61: 113–118

    PubMed  Google Scholar 

  • Mimura T, Rizzello F, Helwig U et al. (2002) Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 16: 909–917

    Article  PubMed  Google Scholar 

  • Mimura T, Rizzello F, Helwig U et al. (2004) Once daily high dose probiotic therapy (VSL-3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108–114

    Article  PubMed  Google Scholar 

  • Mulder CJ, Fockens P, Meijer JW et al. (1996) Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Eur J Gastroenterol Hepatol 8: 549–553

    PubMed  Google Scholar 

  • Neurath MF, Wanitschke R, Peters M et al. (1999) Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 44: 625–628

    PubMed  Google Scholar 

  • Oren R, Arber N, Odes S et al. (2002) Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology 110: 1416–1421

    Article  Google Scholar 

  • Ozuner G, Hull TL, Cartmill J, Fazio VW (1996) Long-term analysis of the use of transanal rectal advancement flaps for complicated anorectal/vaginal fistulas. Dis Colon Rectum 39: 10–14

    Article  PubMed  Google Scholar 

  • Paoluzi OA, Pica R, Marcheggiano A et al. (2002) Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission. Aliment Pharmacol Ther 16: 1751–1759

    Article  PubMed  Google Scholar 

  • Papi C, Luchetti R, Gili L et al. (2000) Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther 14: 1419–1428

    Article  PubMed  Google Scholar 

  • Pearson DC, May GR, Fick G, Sutherland LR (2000). Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev 2: CD000067

    Google Scholar 

  • Penna C, Daude F, Parc R et al. (1993) Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouchanal anastomosis in ulcerative colitis. Dis Colon Rectum 36: 343–348

    Article  PubMed  Google Scholar 

  • Plein K, Hotz J (1993) Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea — a pilot study. Z Gastroenterol 31: 129–134

    Google Scholar 

  • Poggioli G, Stocchi L, Laureti S et al. (1997) Conservative surgical management of terminal ileitis: side-to-side enterocolic anastomosis. Dis Colon Rectum 40: 234–237

    Article  PubMed  Google Scholar 

  • Porschen R. Guidelines of the DGVS (2001) Prevention of carcinoma. German Society of Digestive and Metabolic Diseases. Z Gastroenterol 39: 51–54

    Article  Google Scholar 

  • Rankin GB, Watts HD, Melnyk CS, Kelley ML (1979) National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 77: 914–926

    PubMed  Google Scholar 

  • Rath HC, Caesar I, Roth M, Schölmerich J (1998) Nutritional deficiencies and complications in chronic inflammatory bowel diseases. Med Klin 93: 6–10

    PubMed  Google Scholar 

  • Rembacken BJ, Snelling AM, Hawkey PM et al. (1999) Nonpathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635–639

    Article  PubMed  Google Scholar 

  • Ribeiro MB, Greenstein AJ, Heimann TM et al. (1991) Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet 173: 343–349

    PubMed  Google Scholar 

  • Riordan AM, Hunter JO, Cowan RE et al. (1993) Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 342: 1131–1134

    Article  PubMed  Google Scholar 

  • Rogler G, Scholmerich J (2004) Extraintestinal manifestations of inflammatory bowel disease. Med Klin 99: 123–130

    Article  PubMed  Google Scholar 

  • Ruseler van Embden JG, Schouten WR, van Lieshout LM (1994) Pouchitis: result of microbial imbalance? Gut 35: 658–664

    PubMed  Google Scholar 

  • Sandborn W, McLeod R, Jewell D (2000) Pharmacotherapy for inducing and maintaining remission in pouchitis. Cochrane Database Syst Rev 2: CD001176

    Google Scholar 

  • Sandborn W, Sutherland L, Pearson D et al. (2000) Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2: CD000545

    Google Scholar 

  • Sandborn WJ (1994) Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 107: 1856–1860

    PubMed  Google Scholar 

  • Sandborn WJ, Feagan BG, Hanauer SB et al. (2001) An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology 120: 1330–1338

    Article  PubMed  Google Scholar 

  • Sandborn WJ, Hanauer SB, Katz S et al. (2001) Etanercept for active Crohn's disease: a randomized, double-blind, placebocontrolled trial. Gastroenterology 121: 1088–1094

    Article  PubMed  Google Scholar 

  • Sandborn WJ, Sands BE, Wolf DC et al. (2003) Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebocontrolled, dose-escalation trial. Aliment Pharmacol Ther 17: 1355–1364

    Article  PubMed  Google Scholar 

  • Sandborn WJ, Tremaine WJ, Batts KP et al. (1995) Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 40: 1474–1483

    PubMed  Google Scholar 

  • Sandborn WJ, Tremaine WJ, Schroeder KW et al. (1994) A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 106: 1429–1435

    PubMed  Google Scholar 

  • Sanderson IR, Udeen S, Davies PSW et al. (1987) Remission inducuced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 61: 123–127

    Google Scholar 

  • Sands BE, Bank S, Sninsky CA et al. (1999) Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology 117: 58–64

    PubMed  Google Scholar 

  • Schaudig A, Kock N, von Bary S, Nakano H (1973) Kock's continent ileostomy. Munch Med Wochenschr 115: 290–295

    PubMed  Google Scholar 

  • Schlemminger R, Neufang T, Leister I, Becker H (1999) Laparoscopic stoma technique. Chirurg 70: 656–661

    Article  PubMed  Google Scholar 

  • Schreiber S, Nikolaus S, Malchow H et al. (2001) Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease. Gastroenterology 120: 1339–1346

    Article  PubMed  Google Scholar 

  • Schröder O, Stein J (2003) Methotrexate in IBD. Current status and future aspects. Am J Gastroenterology 98: 530–537

    Article  Google Scholar 

  • Scolapio JS (1999) The role of total parenteral nutrition in the management of patients with acute attacks of IBD. J Clin Gastroenterol 29: 223–224

    Article  PubMed  Google Scholar 

  • Sentongo TA, Semeao EJ, Piccoli DA et al (2000) Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 31: 33–40

    Article  PubMed  Google Scholar 

  • Seo M, Okada M, Yao T, Furukawa H, Matake H (1999) The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol 29: 270–275

    Article  PubMed  Google Scholar 

  • Shen B, Achkar JP, Lashner BA et al. (2001) A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 7: 301–305

    Article  PubMed  Google Scholar 

  • Simms L, Steinhart AH (2001) Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2: CD002913

    Google Scholar 

  • Skelly MM, Logan RF, Jenkins D et al. (2002) Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease. Inflamm Bowel Dis 8: 93–97

    Article  PubMed  Google Scholar 

  • Soetikno RM, Lin OS, Heidenreich PA et al. (2002) Increased risk for colorectal cancer in patients with primary sclerosing cholangitis and ulcerative colitis? A meta-analysis. Gastrointest Endosc 56: 48–54

    Article  PubMed  Google Scholar 

  • Stallmach A, Carstens O (2002) Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm Bowel Dis 8: 213–218

    Article  PubMed  Google Scholar 

  • Stallmach A, Wittig BM, Moser C et al. (2003) Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut 52: 377–382

    Article  PubMed  Google Scholar 

  • Stange EF, Riemann J, Herbay von A et al. (2001) Diagnosis and therapy of ulcerative colitis — results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 39: 19–70 (update 2004)

    Article  Google Scholar 

  • Stange EF, Schreiber S, Fölsch U et al. (2003) Diagnosis and therapy of Crohn diseases—results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 41: 19–70

    Article  PubMed  Google Scholar 

  • Steinhart AH, Ewe K, Griffiths AM et al. (2001) Corticosteroids for maintaining remission of Crohn's disease. Cochrane Database Syst Rev: CD000301

    Google Scholar 

  • Sutherland L, Roth D, Beck P et al. (2000) Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis. Cochrane Database Syst Rev: CD000544

    Google Scholar 

  • Swinson CM, Perry J, Lumb M, Levi AJ (1981) Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis. Gut 22: 456–461

    PubMed  Google Scholar 

  • Targan SR, Hanauer SB, Van Deventer SJ et al. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337: 1029–1035

    Article  PubMed  Google Scholar 

  • Thomsen OO, Cortot A, Jewell D et al. (1998) A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med 339: 370–374

    Article  PubMed  Google Scholar 

  • Tilg H, Vogelsang H, Ludwiczek O et al. (2003) A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 52: 1728–1733

    Article  PubMed  Google Scholar 

  • Tjandra JJ, Fazio VW, Milsom JW et al. (1993) Omission of temporary diversion in restorative proctocolectomy—is it safe? Dis Colon Rectum 36: 1007–1014

    Article  PubMed  Google Scholar 

  • Tremaine WJ, Sandborn WJ, Wolff BG et al. (1997) Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 11: 1041–1046

    Article  PubMed  Google Scholar 

  • Tsunoda A, Talbot IC, Nicholls RJ (1990) Incidence of dysplasia in the anorectal mucosa in patients having restorative proctocolectomy. Br J Surg 77: 506–508

    PubMed  Google Scholar 

  • Turunen UM, Farkkila MA, Hakala K et al. (1998) Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 115: 1072–1078

    PubMed  Google Scholar 

  • Van Assche G, D'Haens G, Noman M et al. (2003) Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125: 1025–1031

    Article  PubMed  Google Scholar 

  • Van den Bosch F, Kruithof E, De Vos M et al. (2000) Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 356: 1821–1822

    Article  PubMed  Google Scholar 

  • Vasiliauskas EA, Kam LY, Abreu-Martin MT et al. (1999) An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology 117: 1278–1287

    PubMed  Google Scholar 

  • Venturi A, Gionchetti P, Rizzello F et al. (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 13: 1103–1108

    Article  PubMed  Google Scholar 

  • Veress B, Reinholt FP, Lindquist K, Lofberg R, Liljeqvist L (1995) Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 109: 1090–1097

    Article  PubMed  Google Scholar 

  • Verma S, Brown S, Kirkwood B, Giaffer MH (2000) Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol 95: 735–739

    PubMed  Google Scholar 

  • Verma S, Holdsworth CD, Giaffer MH (2000) Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand J Gastroenterol 36: 383–388

    Article  Google Scholar 

  • Vernia P, Annese V, Bresci G et al. (2003) Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 33: 244–248

    Article  PubMed  Google Scholar 

  • Williamson PR, Hellinger MD, Larach SW, Ferrara A (1995) Twenty-year review of the surgical management of perianal Crohn's disease. Dis Colon Rectum 38: 389–392

    Article  PubMed  Google Scholar 

  • Wolff BG, Culp CE, Beart RW et al. (1985) Anorectal Crohn's disease. A long-term perspective Dis Colon Rectum 28: 709–711

    Google Scholar 

  • Yacyshyn BR, Chey WY, Goff J et al. (2002) Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut 51: 30–36

    Article  PubMed  Google Scholar 

  • Zachos M, Tondeur M, Griffiths AM (2001) Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev: CD000542

    Google Scholar 

Download references

Authors
  1. K. Herrlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. F. Stange
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. J. Buhr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. J. Kroesen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II, Schwerpunkte Gastroenterologie/Hepatologie/Pneumologie/Allergologie, Universitätsklinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main

    Wolfgang F. Caspary

  2. Medizinische Klinik und Poliklinik II, Universitätsklinikum Leipzig, Philipp-Rosenthal-Str. 27, 04103, Leipzig

    Joachim Mössner

  3. Zentrum Innere Medizin, Medizinische Klinik II, Gastroenterologie/Hepatologie/Pneumologie/Allergologie/Klinische Ernährung, Theodor-Stern-Kai 7, 60590, Frankfurt am Main

    Jürgen Stein

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Herrlinger, K., Stange, E.F., Schröder, O., Stein, J., Buhr, H.J., Kroesen, A.J. (2005). Chronisch entzündliche Darmerkrankungen. In: Caspary, W.F., Mössner, J., Stein, J. (eds) Therapie gastroenterologischer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26660-7_26

Download citation

  • DOI: https://doi.org/10.1007/3-540-26660-7_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44174-8

  • Online ISBN: 978-3-540-26660-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation